Mind + Muscle

technical minds + legal muscle


business issues

IP In Clinical Trials

Hot Topics
IP Issues Associated With Drug Development

IP Issues Associated With Drug Development

  • 08.08.13
  • Sterne, Kessler, Goldstein & Fox

Biotechnology companies and universities discover a large percentage of innovative drugs approved by the U.S. Food and Drug Administration each year. These companies, however, are sometimes unprepared for the intellectual property considerations that arise as a promising drug (either their own or one licensed from a university) progresses through clinical trials.

Numerous issues emerge that go far beyond procuring patent protection for the product and the company's platform technology. They include seeking patent protection for downstream discoveries, the renewed importance of process patents, data exclusivity, inventorship disputes, and clearance of third party patents covering commercial manufacturing methods and patient administration protocols.

read more

IP in Clinical Trials: Videos

IP in Clinical Trials Resources

IP In Clinical Trials: News & Articles




Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.